
Health Rounds: Roche’s Tecentriq reduces recurrence, deaths for certain colon cancer patients
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)) By Nancy Lapid (Reuters) -Adding Roche’s immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon …